Many previous studies have demonstrated that minor-frequency pretreatment T790M mutation (preT790M) could be detected by ultrasensitive methods in a considerable number of treatment-naïve, epidermal growth factor receptors (EGFR)-mutated, non-small cell lung cancer (NSCLC) cases. |